Prolonged therapy of chronic hepatitis C with ribavirin.
about
Replicative Homeostasis III: implications for antiviral therapy and mechanisms of response and non-responseRibavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivoPerspectives for the treatment of infections with Flaviviridae.Review article: glycyrrhizin as a potential treatment for chronic hepatitis C.Current status and future directions in the management of chronic hepatitis C.Role of ribavirin in HCV treatment response: now and in the future.Interferon combination therapy for HIV/hepatitis C virus coinfection.Mechanism of action of ribavirin in the treatment of chronic hepatitis C.Review article: management of chronic hepatitis C in patients with contraindications to anti-viral therapy.Persistent hepatitis C virus infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1.Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy.Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes.Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy.Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection.Ribavirin inhibits protein synthesis and cell proliferation induced by mitogenic factors in primary human and rat hepatocytes.Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: outcomes from a population-based cohort.Treatment with ribavirin and interferon-alpha reduces interferon-gamma expression in patients with chronic hepatitis C.Interferon alpha with ribavirin for the treatment of chronic hepatitis C in non-responders or relapsers to interferon monotherapy.Ribavirin monotherapy in patients with chronic hepatitis C: a retrospective study of 95 patients.
P2860
Q27478215-E16A3508-F744-4382-A0F7-875925F57A8DQ27480732-60074712-B80E-486C-A108-06EB2207CF99Q33812419-E59928BF-3D2C-4968-B661-3A512C792E3DQ34466343-7DF07073-5C6B-4209-B505-CF1E02F9D491Q35887719-87C20C66-A1BA-4395-951E-432D6873F749Q37693948-333548DC-1B47-4F8D-ADAA-3A5763B4E73EQ37931258-B34BBAF0-A084-48CA-BB2F-D31E018A596AQ37940977-E5AEF599-80C5-4E70-9A5E-BC8FC91D9953Q38166445-0FD7B2EB-DF46-4B31-9720-0799AA583A75Q38262107-33BB07FA-227D-4143-83EB-4BEC4FEA2844Q40605824-D2DDC271-9694-4D24-822B-29F910AA6460Q41156164-882ED7E5-E0A6-48A2-9371-8418FC8DC840Q43035368-30FEAFDF-8257-4E16-94E8-5EB48FF7CEA1Q44211421-328B3284-EDF0-4420-81D8-7A84D2923B3BQ44980536-D35B703B-FA91-4CB2-B176-0392DC173406Q48604431-74138001-827B-49FE-B956-1E8D03FE4367Q50585994-8682B0A5-7C8A-4CE4-B07E-FC11C01030BEQ50588093-8E2C58C6-05BA-429C-930E-3DA2E77732E3Q50588155-A027CC20-66F3-49EE-9FA4-70FCA099F1A9
P2860
Prolonged therapy of chronic hepatitis C with ribavirin.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Prolonged therapy of chronic hepatitis C with ribavirin.
@en
Prolonged therapy of chronic hepatitis C with ribavirin.
@nl
type
label
Prolonged therapy of chronic hepatitis C with ribavirin.
@en
Prolonged therapy of chronic hepatitis C with ribavirin.
@nl
prefLabel
Prolonged therapy of chronic hepatitis C with ribavirin.
@en
Prolonged therapy of chronic hepatitis C with ribavirin.
@nl
P2093
P2860
P1476
Prolonged therapy of chronic hepatitis C with ribavirin.
@en
P2093
Conjeevaram H
Di Bisceglie AM
Hoofnagle JH
P2860
P304
P356
10.1111/J.1365-2893.1996.TB00050.X
P577
1996-09-01T00:00:00Z